Cargando…
Inter-institutional heterogeneity in outcomes of chemotherapy for metastatic gastric cancer: correlative study in the JCOG9912 phase III trial
BACKGROUND: The standard chemotherapy regimen for gastric cancer has been established by several phase III trials. However, few studies have evaluated inter-institutional heterogeneity in randomised trials; such research may assure the generalisability of the results and also the reliability of the...
Autores principales: | Kurokawa, Y, Boku, N, Yamaguchi, T, Ohtsu, A, Mizusawa, J, Nakamura, K, Fukuda, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070211/ https://www.ncbi.nlm.nih.gov/pubmed/27843586 http://dx.doi.org/10.1136/esmoopen-2015-000031 |
Ejemplares similares
-
Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)
por: Tahara, Makoto, et al.
Publicado: (2015) -
Usefulness of an S-1 dosage formula: an exploratory analysis of randomized clinical trial (JCOG1001)
por: Kawakami, Takeshi, et al.
Publicado: (2022) -
A Phase II Trial of Combined Treatment of Endoscopic Mucosal Resection and Chemoradiotherapy for Clinical Stage I Esophageal Carcinoma: Japan Clinical Oncology Group Study JCOG0508
por: Kurokawa, Yukinori, et al.
Publicado: (2009) -
Patient-reported outcome and quality of life research policy: Japan Clinical Oncology Group (JCOG) policy
por: Ishiki, Hiroto, et al.
Publicado: (2023) -
Randomized controlled phase III trial to investigate superiority of robot-assisted gastrectomy over laparoscopic gastrectomy for clinical stage T1-4aN0-3 gastric cancer patients (JCOG1907, MONA LISA study): a study protocol
por: Makuuchi, Rie, et al.
Publicado: (2023)